Phase III multi-centre open-label randomized controlled trial of selective internal radiation therapy (SIRT) versus sorafenib in locally advanced hepatocellular carcinoma: The SIRveNIB study - Pierce, H W; Chow, M G; Asia-Paciifc Hepatocellular Carcinoma Trials Group; National Cancer Center Singapore, Singapore, Singapore; Singapore Clinical Research Insititute, Singapore, Singapore (2017)
(suppl; abstr 4002)